By utilizing radiotracers that bind specifically to PSMA-expressing cells, and by colocalizing them in conjunction with morphologic cross-sectional imaging techniques (CT or MRI), a more precise diagnostic evaluation can be achieved, enabling the identification of even smaller metastases and providing a detailed assessment of the local tumor environment. This evidence concerns the gene FOLH1 and neoplasm.